Slentrol

RSS

Withdrawn

This medicine's authorisation has been withdrawn

dirlotapide
MedicineVeterinaryWithdrawn

Dutch is available via eTranslation, the European Commission's machine translation service.

Translate to Dutch | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Slentrol has been withdrawn at the request of the marketing authorisation holder.

български (BG) (279.69 kB - PDF)

Bekijk

español (ES) (239.85 kB - PDF)

Bekijk

čeština (CS) (283.94 kB - PDF)

Bekijk

dansk (DA) (239 kB - PDF)

Bekijk

Deutsch (DE) (241.8 kB - PDF)

Bekijk

eesti (ET) (237.14 kB - PDF)

Bekijk

ελληνικά (EL) (282.67 kB - PDF)

Bekijk

français (FR) (245.68 kB - PDF)

Bekijk

italiano (IT) (238.08 kB - PDF)

Bekijk

latviešu (LV) (283.06 kB - PDF)

Bekijk

lietuvių (LT) (251.47 kB - PDF)

Bekijk

magyar (HU) (253.42 kB - PDF)

Bekijk

Malti (MT) (265.77 kB - PDF)

Bekijk

Nederlands (NL) (217.72 kB - PDF)

Bekijk

polski (PL) (282.55 kB - PDF)

Bekijk

português (PT) (218.29 kB - PDF)

Bekijk

română (RO) (242.81 kB - PDF)

Bekijk

slovenčina (SK) (260.4 kB - PDF)

Bekijk

slovenščina (SL) (252.65 kB - PDF)

Bekijk

suomi (FI) (237.94 kB - PDF)

Bekijk

svenska (SV) (239.22 kB - PDF)

Bekijk

Product information

български (BG) (1.12 MB - PDF)

Bekijk

español (ES) (413.23 kB - PDF)

Bekijk

čeština (CS) (559.01 kB - PDF)

Bekijk

dansk (DA) (619.26 kB - PDF)

Bekijk

Deutsch (DE) (409.78 kB - PDF)

Bekijk

eesti (ET) (394.94 kB - PDF)

Bekijk

ελληνικά (EL) (1.78 MB - PDF)

Bekijk

français (FR) (455.26 kB - PDF)

Bekijk

italiano (IT) (432.39 kB - PDF)

Bekijk

latviešu (LV) (543.86 kB - PDF)

Bekijk

lietuvių (LT) (475.04 kB - PDF)

Bekijk

magyar (HU) (577.53 kB - PDF)

Bekijk

Malti (MT) (631.26 kB - PDF)

Bekijk

Nederlands (NL) (419.67 kB - PDF)

Bekijk

polski (PL) (601.64 kB - PDF)

Bekijk

português (PT) (402.62 kB - PDF)

Bekijk

română (RO) (490.98 kB - PDF)

Bekijk

slovenčina (SK) (616.03 kB - PDF)

Bekijk

slovenščina (SL) (568.91 kB - PDF)

Bekijk

suomi (FI) (408.3 kB - PDF)

Bekijk

svenska (SV) (413.86 kB - PDF)

Bekijk

Íslenska (IS) (418.64 kB - PDF)

Bekijk

norsk (NO) (405.73 kB - PDF)

Bekijk
Latest procedure affecting product information:IAIN/0007/G
15/01/2015

български (BG) (202.54 kB - PDF)

Bekijk

español (ES) (148.22 kB - PDF)

Bekijk

čeština (CS) (192.56 kB - PDF)

Bekijk

dansk (DA) (151.57 kB - PDF)

Bekijk

Deutsch (DE) (152.17 kB - PDF)

Bekijk

eesti (ET) (147.88 kB - PDF)

Bekijk

ελληνικά (EL) (200.73 kB - PDF)

Bekijk

français (FR) (474.14 kB - PDF)

Bekijk

italiano (IT) (148.51 kB - PDF)

Bekijk

latviešu (LV) (202.11 kB - PDF)

Bekijk

lietuvių (LT) (191.42 kB - PDF)

Bekijk

magyar (HU) (188.69 kB - PDF)

Bekijk

Malti (MT) (194.75 kB - PDF)

Bekijk

Nederlands (NL) (151.46 kB - PDF)

Bekijk

polski (PL) (176.01 kB - PDF)

Bekijk

português (PT) (151.81 kB - PDF)

Bekijk

română (RO) (188.05 kB - PDF)

Bekijk

slovenčina (SK) (195.92 kB - PDF)

Bekijk

slovenščina (SL) (189.87 kB - PDF)

Bekijk

suomi (FI) (147.96 kB - PDF)

Bekijk

svenska (SV) (151.54 kB - PDF)

Bekijk

Íslenska (IS) (151.76 kB - PDF)

Bekijk

norsk (NO) (148.31 kB - PDF)

Bekijk

Product details

Name of medicine
Slentrol
Active substance
dirlotapide
International non-proprietary name (INN) or common name
dirlotapide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QA08AB91

Pharmacotherapeutic group

Antiobesity preparations, excl. diet products

Therapeutic indication

As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

Authorisation details

EMA product number
EMEA/V/C/000116
Marketing authorisation holder
Zoetis Belgium SA

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Marketing authorisation issued
13/04/2007
Revision
7

Assessment history

This page was last updated on

Share this page